Active plantar fibromatosis occurring under anti-TNFα therapy for spondyloarthritis.
Rheumatology Department, Clermont-Ferrand Teaching Hospital, place Henri-Dunant, 63000 Clermont-Ferrand, France. Electronic address: mcouderc@chu-clermontferrand.fr.
Marion
M
Couderc
Anatomopathology laboratory, Clermont-Ferrand Teaching Hospital, place Henri-Dunant, 63000 Clermont-Ferrand, France.
Jean-Louis
JL
Kemeny
Radiology Department, Clermont-Ferrand Teaching Hospital, place Henri-Dunant, 63000 Clermont-Ferrand, France.
Agnès
A
Lhoste
Rheumatology Department, Clermont-Ferrand Teaching Hospital, place Henri-Dunant, 63000 Clermont-Ferrand, France.
Martin
M
Soubrier
Rheumatology Department, Clermont-Ferrand Teaching Hospital, place Henri-Dunant, 63000 Clermont-Ferrand, France.
Jean-Jacques
JJ
Dubost
D000068879:Adalimumab / Q000009:adverse effects* / Q000627:therapeutic use; D000328:Adult; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D000068800:Etanercept / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D000071380:Fibromatosis, Plantar / Q000139:chemically induced* / Q000000981:diagnostic imaging*; D005500:Follow-Up Studies; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D018570:Risk Assessment; D012720:Severity of Illness Index; D025241:Spondylarthritis / Q000175:diagnosis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000037:antagonists & inhibitors
D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D000068800:Etanercept
Adalimumab; Ankylosing spondylarthritis; Etanercept; Fibromatosis; Ledderrhose; TNFα blockers